Many different assays have been developed to assess chemosensitivity of malignant cells. The use of the clonogenic assay has a number of theoretical (Weisenthal & Lippman, 1985) but especially practical difficulties, such as a long incubation time and low plating efficiencies resulting in adequate colony forming in only 40% of all specimens (Carney & Winkler, 1985) . Recently, Ajani et al. (1987) described a cell culture system with a plating efficiency of 3%, allowing drug testing in about 70% of tumours. Unfortunately, up to now such plating efficiency is not obtained in specimens from patients with acute lymphoblastic leukaemia (ALL). Even if one succeeds in culturing ALL cells then a mean plating efficiency of only 0.04% will be obtained (Touw et al., 1986) . Because of this, short-term tests might be more appropriate for drug sensitivity testing of ALL cells. The most promising short-term test is the dye exclusion assay (DEA) developed by Weisenthal et al. (1983a) . Others (Bosanquet et al., 1983; Bird et al., 1986) have adapted this assay using the microtitre format to study chemosensitivity of leukaemic patients. A number of authors have shown that the end-point of the DEA is comparable to that of the clonogenic assay (Weisenthal et al., 1983b; Carmichael et al., 1987; Laurent et al., 1986; Bird et al., 1987) . With regard to the correlation with clinical responsiveness, which is ultimately the most valid comparison of different assays, the results of the DEA compared favourable with those of other in vitro chemosensitivity assays (Weisenthal & Lippman, 1985; Bird et al., 1988) . Therefore the DEA is a useful tool to study drug sensitivity of ALL cells. However, this method is still very labour-intensive and subject to observer error. These problems can be overcome with the recently developed assay based on the reduction of ]-2,5-diphenyl tetrazolium bromide) to a formazan by living but not by dead cells (Mosmann, 1983) . The MTT assay can be performed in microtitre plates and the formazan production can be quantitated with a microplate spectrophotometer. Therefore it provides a simple, automated and highly efficient method for chemosensitivity testing.
Up to now the MTT assay has been used to assess drug sensitivity in established cell lines (Alley et al., 1988; Carmichael et al., 1987; Cole, 1986; Finlay et al., 1986; Park et al., 1987; Twentyman & Luscombe, 1987 (Pieters et al., 1988) . The comparison of the MTT assay with the DEA is described in the present report. myeloid blast cell crisis. Lymphoblasts were isolated and washed as described before (Pieters et al., 1988) . Specimens were tested after thawing of cells that had been frozen in liquid nitrogen. After cryopreservation the mean percentage blast cells was 93% (range 80-98). In one patient a comparison was made between the same specimen before and after cryopreservation resulting in identical doseresponse curves (see Figure 1 ). ) and after (------) cryopreservation. Abbreviations as in Table I . Test design The MTT assay and DEA were run concurrently for each patient using 1 x 106 cellsml-l in RPMI-FCS plus supplement as described before (Pieters et al., 1988) . Aliquots (80,ul) of this suspension were dispensed into 96-well round-bottomed microtitre plates which already contained 20M1 of drug dilutions. The 96-well plates were incubated at 37°C for 2 days. Storage and dissolving of drugs were done as previously described (Pieters et al., 1988) .
MTT assay After 2 days incubation, 10,l1 MTT (Sigma) solution (5mgml-1) was added to each well and after shaking for 1min the plate was incubated further for 6h.
Formazan crystals were dissolved with 100pI of 0.04N HClisopropyl alcohol. The absorbance or optical density (OD) was quantitated with a microplate spectrophotometer (Titertek Multiskan MCC 340) at 540nm. Wells containing no cells and no drugs were used for blanking the spectrophotometer. Leukaemic cell survival (LCS) for a well was expressed as percentage of untreated control wells. The mean coefficient of variation of OD of control wells (n =8 for each patient) was 9.8%. We showed a linear relationship (r2= 0.998) between OD and cell number in the range of 80 x 103 cells (i.e. the number of cells seeded in a well) to 1.25 x 103 cells (Pieters et al., 1988) .
Dye exclusion assay (DEA) The DEA was carried out using a modification of the assay described by Weisenthal et al. (1983a , b), Bird et al. (1986 and Bosanquet et al. (1983) Table I . In 26 cases (62%) the LCS50 was identical and in 38 cases (90%) the difference in LCS50 was _2 drug dilutions. The main difference was the required processing time. The MTT assay took only 15min of technician time after the 2 days incubation compared to 12-16h for the DEA.
Sometimes LCS values can exceed 100%. This has also been observed in other studies (Park et al., 1987; Alley et al., 1988) . It is not clear which factor causes this effect. The excess may fall within the coefficient of variation in some cases. Higher values in the DEA might be due to observer error, for example Dox in Figure 3 . If the excess tends to take place in all drugs then it is likely that the control value has been assessed too low as in Figure 2 . With respect to Pred it is of interest that this drug stimulates in vitro leukaemic cell growth in some cases (Salem et al., 1988) . Dose-response curves covering the LCS-range from 0 to 100% were found for 6-TG, 6-MP and VCR. In the case of Dox and Pred the used doses might have been too low to distinguish between sensitivity and resistance. In two ALL patients in which Dox was not effective, a 4-day incubation with a wider range of concentrations resulted in doseresponse curves at 1.6-25 jg/ml. Using a 4-day incubation of Pred in the five cases in which Pred was not effective, this curve was demonstrable in two additional cases. The fact that a number of ALL patients exhibit a poor response to initial steroid therapy (Riehm et al., 1987) might also explain the lack of in vitro effect of Pred in some cases. At present we use a 4-day MTT assay with the highest doses of Pred and Dox being 200 pgml-1 and 8Mgml-1 respectively. A 4-day incubation of MTX in four patients showed a cytotoxic effect in all patients (LCS=35-70%).
It should be stressed that chemosensitivity assays are more suitable for detecting the relative efficacy of drugs than the absolute effect of a certain drug dose. In this respect it is of interest to note that the ALL patient with a BM relapse was less sensitive to VCR (LCS50= 50ng ml-1) than initial ALL patients (LC 5 0=0.8-3.lngml-1). This is in concordance with the findings of Weisenthal et al. (1987) . Using the DEA they showed that relapsed ALL patients were significantly less sensitive to VCR than initial ALL patients and that the relative resistance to VCR could be circumvented by protein kinase C inhibitors. This has led to currently ongoing clinical trials of these inhibitors, illustrating the fact that the DEA is a useful tool to study chemosensitivity in ALL patients.
In testing chemosensitivity of cell lines, the MTT assay has been shown to give results comparable to those obtained by cellular protein assay (Alley et al., 1988) , viable cell counting (Finlay et al., 1986; Twentyman & Luscombe, 1987; Alley et al., 1988) and clonogenic and dye exclusion assays (Carmichael et al., 1987; Chang & Gregory, 1987; Harker et al., 1987) . However, with the exception of one paper in Japanese (Hongo et al., 1987) , there had been no data available on the use of the MTT assay in drug sensitivity testing of patient samples. After having this paper translated, it appeared that the MTT assay often failed on initial ALL samples because of the low control cell viability. In accordance with the finding of Bird et al. (1986) , we showed that enrichment of the medium with insulin, transferrin and selenite significantly increased the ALL cell viability which allowed us to adapt the MTT assay for testing leukaemic cells obtained directly from patients (Pieters et al., 1988) . In the present study we showed that the MTT assay and the DEA correlated well for chemosensitivity testing in childhood leukaemia. In both assays the technical success rate was 7/10, similar dose-response curves were observed in all patients and a good correlation was observed for the LCS50 of both assays. However, the MTT assay is much more efficient and rapid and not subject to observer error. G. & 6 others (1987) .
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